- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06261229
The Effectiveness of Intermittent Fasting and Behavioral Economics Intervention on Weight Control in Obese Patients
This study is a parallel randomized controlled trial (RCT). To determine the effect of intermittent fasting, intermittent fasting with behavioral economics, and intensive lifestyle modification on nutritional status; the differences between HOMA-IR, body weight change, and body composition in obese people.
Each participant will be randomized to receive the intervention (intermittent fasting, intermittent fasting with behavioral economics, or intensive lifestyle modification.
The study protocol will be explained to the eligible participant and informed written consent will be obtained.
The total sample size will be 123 participants. Blood and urine samples will be collected at baseline and each follow-up visit including 1-month, 2-months, 6-month, and 12-months, respectively for further study to find out the mechanisms of weight loss, weight regain, and the improvement in the metabolic disease.
Study Overview
Status
Detailed Description
The investigators will collect the participant characteristics (age, gender, smoking history, comorbid diseases including history of previous stroke, myocardial infarction, angina, hypertension, dyslipidemia, T2DM, risk of osteoporosis, and all medication lists) at the first visit.
Physiological parameters:
- Body composition will be assessed by the Bioelectrical Impedance at the first visit and at each follow-up visit (1 month, 2 months, 4 months, 6 months, 9 months, and 12 months).
- Peripheral venous blood sample (15mL: clotted blood 9mL and EDTA blood 6 mL) and urinalysis will be collected from all participants at baseline and each follow-up visit (1-month, 2-months, 6-month, and 12 months). Blood samples will be immediately centrifuged and plasma/serum will be placed in a -80 Celsius freezer until analysis (glucose, HbA1C, insulin, albumin, creatinine, uric acid, lipid profile, liver function test, kidney function test, thyroid function test, and other biochemical).
Three questionnaires will be collected:
1) Global physical activity questionnaire, sleep questionnaire, and satiety visual analog score questionnaire will be obtained at the first visit and at each follow-up visit (1 month, 2 months, 4 months, 6 months, 9 months, and 12 months).
- Nutritional status will be assessed by history, 24-hour dietary recall, 3days food record, and physical examinations at the first visit and at each follow-up visit (1 month, 2 months, 4 months, 6 months, 9 months, and 12 months).
Regarding the descriptive statistical analysis, all the data will be tested for normality. Data will be presented as Mean ± standard deviation or Median (interquartile ranges) for continuous variables and frequency (%) for binary and categorical variables. The continuous variables will be compared by using Independent samples T-test or Analysis of variance (ANOVA) followed by multiple comparisons with the Bonferroni method. Test results of categorical variables will be evaluated by Chi-square or Fisher exact test as appropriate. Results will be deemed statistically significant at a P-value < 0.05.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Bangkok
-
Ratchathewi, Bangkok, Thailand, 10400
- Mahidol University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Aged 18-65 year
- BMI start at 25.0 kg/m2 (above 24.99 kg/m2)
- Weight change less than 5% in 6-month
- Ability and willingness to provide informed consent
Exclusion Criteria:
- Pregnant women or breed feeding
- Kidney disease/ Liver disease
- Abnormal Thyroid hormone, abnormal GI function
- Postoperative bariatric surgery
- Drug control weight or reduce appetite
- Drug abuse
- Mental illness
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Intermittent fasting
The participant will consume food about/ within 8 hours per day
|
The participant will consume food about/ within 8-hour per day
|
Experimental: Intermittent fasting + Behavioral economic
The participant will consume food about/ within 8-hour per day.
They will be rewarded as money when they achieve their weight loss goal or/and successfully do intermittent fasting 5 days/week.
|
The participant will consume food about/ within 8-hour per day.
They will be received a reward as money when achieve weight loss goal or/and success doing intermittent fasting 5 days/week
Other Names:
|
Experimental: Intensive Lifestyle Modification
Advice about nutrition knowledge, healthy eating diet, diet prescription, and exercise
|
Advice about nutrition knowledge, healthy eating diet, diet prescription, and exercise
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
HOMR-IR (index)
Time Frame: Change from Baseline HOMR-IR at 6 months and 12 months
|
Homeostatic Model Assessment for Insulin Resistance
|
Change from Baseline HOMR-IR at 6 months and 12 months
|
Body mass index (kg/m^2)
Time Frame: Change from Baseline Body mass index at 1 month, 2 months, 4 months, 6 months, 9 months, and 12 months
|
Body weight and height will be combined to report BMI in kg/m^2
|
Change from Baseline Body mass index at 1 month, 2 months, 4 months, 6 months, 9 months, and 12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
FBS (mg/dl)
Time Frame: Change from Baseline FBS (mg/dl) at 1 month, 2 months, 6 months, and 12 months
|
Fasting blood glucose
|
Change from Baseline FBS (mg/dl) at 1 month, 2 months, 6 months, and 12 months
|
HbA1C (%)
Time Frame: Change from Baseline HbA1C (%) at 1 month, 2 months, 6 months, and 12 months
|
Average blood sugar levels over the past 3 months
|
Change from Baseline HbA1C (%) at 1 month, 2 months, 6 months, and 12 months
|
Albumin (g/L)
Time Frame: Change from Baseline Albumin (g/L) at 1 month, 2 months, 6 months, and 12 months
|
a blood plasma protein synthesized in the liver
|
Change from Baseline Albumin (g/L) at 1 month, 2 months, 6 months, and 12 months
|
Creatinine (mg/dL)
Time Frame: Change from Baseline Creatinine (mg/dL) at 1 month, 2 months, 6 months, and 12 months
|
a waste product that comes from the normal wear and tear on muscles of the body
|
Change from Baseline Creatinine (mg/dL) at 1 month, 2 months, 6 months, and 12 months
|
Alanine transaminase (ALT) U/L
Time Frame: Change from Baseline Alanine transaminase (ALT) U/L at 1 month, 2 months, 6 months, and 12 months
|
ALT is commonly measured clinically as part of liver function tests
|
Change from Baseline Alanine transaminase (ALT) U/L at 1 month, 2 months, 6 months, and 12 months
|
Aspartate transaminase (AST) U/L
Time Frame: Change from Baseline Aspartate transaminase (AST) U/L at 1 month, 2 months, 6 months, and 12 months
|
AST is commonly measured clinically as part of liver function tests
|
Change from Baseline Aspartate transaminase (AST) U/L at 1 month, 2 months, 6 months, and 12 months
|
Uric acid (mg/dL)
Time Frame: Change from Baseline Uric acid (mg/dL) at 1 month, 2 months, 6 months, and 12 months
|
Change from Baseline Uric acid (mg/dL) at 1 month, 2 months, 6 months, and 12 months
|
|
Total cholesterol (mg/dL)
Time Frame: Change from Baseline Total cholesterol (mg/dL) at 1 month, 2 months, 6 months, and 12 months
|
Change from Baseline Total cholesterol (mg/dL) at 1 month, 2 months, 6 months, and 12 months
|
|
HDL-C (mg/dL)
Time Frame: Change from Baseline HDL-C (mg/dL) at 1 month, 2 months, 6 months, and 12 months
|
High-density lipoprotein cholesterol
|
Change from Baseline HDL-C (mg/dL) at 1 month, 2 months, 6 months, and 12 months
|
LDL-C (mg/dL)
Time Frame: Change from Baseline LDL-C (mg/dL) at 1 month, 2 months, 6 months, and 12 months
|
Low-density lipoprotein cholesterol
|
Change from Baseline LDL-C (mg/dL) at 1 month, 2 months, 6 months, and 12 months
|
Triglycerides (mg/dL)
Time Frame: Change from Baseline Triglycerides (mg/dL) at 1 month, 2 months, 6 months, and 12 months
|
Change from Baseline Triglycerides (mg/dL) at 1 month, 2 months, 6 months, and 12 months
|
|
Blood Urea Nitrogen (BUN) (mg/dL)
Time Frame: Change from Baseline Blood Urea Nitrogen (BUN) (mg/dL) at 1 month, 2 months, 6 months, and 12 months
|
Change from Baseline Blood Urea Nitrogen (BUN) (mg/dL) at 1 month, 2 months, 6 months, and 12 months
|
|
Urine albumin-creatinine ratio (UACR) (mg/g)
Time Frame: Change from Baseline Urine albumin-creatinine ratio (UACR) (mg/g) at 1 month, 2 months, 6 months, and 12 months
|
Change from Baseline Urine albumin-creatinine ratio (UACR) (mg/g) at 1 month, 2 months, 6 months, and 12 months
|
|
Energy from food (kilocalories)
Time Frame: Change from Baseline Energy from food (kilocalories) at 1 month, 2 months, 4 months, 6 months, 9 months, and 12 months
|
Energy from food (kilocalories) assess by 24hour-dietary recall and 3days food record
|
Change from Baseline Energy from food (kilocalories) at 1 month, 2 months, 4 months, 6 months, 9 months, and 12 months
|
Collaborators and Investigators
Sponsor
Collaborators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- MURA2022/230
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Weight Loss
-
United States Army Research Institute of Environmental...USDA Grand Forks Human Nutrition Research Center; Eastern Michigan UniversityCompletedWeight Loss | Bone Loss | Muscle LossUnited States
-
Case Comprehensive Cancer CenterUniversity Hospitals Seidman Cancer CenterRecruitingUnintentional Weight Loss and Cancer: A Prospective Trial of Patient-centered Weight Tracking CombinUnintended Weight LossUnited States
-
Zhen Jun WangUnknownSleeve Gastrectomy | Excessive Weight Loss | Total Weight Loss | Jejunojejunal Bypass | UncutChina
-
HealthPartners InstituteNational Cancer Institute (NCI)Completed
-
Dana-Farber Cancer InstituteCompletedWeight Loss Program After Cancer DiagnosisUnited States
-
Medical University of ViennaCompleted
-
Power Life Sciences Inc.Not yet recruitingGastric Bypass | Weight Loss Surgery
-
University at BuffaloHarvard Medical School (HMS and HSDM)TerminatedWeight Loss | Appetite LossUnited States
-
Duke UniversityNational Institute on Aging (NIA)Suspended
-
Drexel UniversityUniversity of PennsylvaniaCompletedObesity | Overweight | Weight Loss MaintenanceUnited States
Clinical Trials on Intermittent fasting
-
H. Lee Moffitt Cancer Center and Research InstituteNot yet recruitingPancreatitis | Pancreatitis, Chronic | Pancreatitis, Acute | Pancreas Disease | Acute Recurrent PancreatitisUnited States
-
Ohio State UniversityNational Psoriasis FoundationRecruitingPsoriasis | Psoriatic ArthritisUnited States
-
Menoufia UniversityRecruitingLocally Advanced Breast Cancer | Intermittent FastingEgypt
-
University of CalgaryCrohn's and Colitis FoundationNot yet recruiting
-
Washington University School of MedicineCompletedRelapsing Remitting Multiple SclerosisUnited States
-
Charite University, Berlin, GermanyWestfälische Wilhelms-Universität MünsterCompleted
-
Istanbul Training and Research HospitalCompleted
-
Ministry of Health, MalaysiaCompletedObesity | Intermittent FastingMalaysia
-
Duke UniversityWithdrawnBreast CancerUnited States
-
Intermountain Health Care, Inc.CompletedIntermittent FastingUnited States